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The transcriptional coactivators PGC-1a and PGC-
1b are widely thought to be required for mitochon-
drial biogenesis and fiber typing in skeletal muscle.
Here, we show that mice lacking both PGC-1s in
myocytes do indeed have profoundly deficient
mitochondrial respiration but, surprisingly, have
preserved mitochondrial content, isolated muscle
contraction capacity, fiber-type composition, in-
cage ambulation, and voluntary running capacity.
Most of these findings are recapitulated in cell
culture and, thus, are cell autonomous. Functional
electron microscopy reveals normal cristae density
with decreased cytochrome oxidase activity. These
data lead to the following surprising conclusions:
(1) PGC-1s are in fact dispensable for baseline mus-
cle function, mitochondrial content, and fiber typing,
(2) endurance fatigue at low workloads is not limited
by muscle mitochondrial capacity, and (3) mitochon-
drial content and cristae density can be dissociated
from respiratory capacity.
INTRODUCTION
Mitochondria in skeletal muscle serve diverse functions and are
critical for health. Human mutations in mitochondrial DNA
(mtDNA) often lead to muscle dystrophy (Seneca et al., 2001;
Wallace, 2005). Aberrant mitochondrial function has been pro-
posed to contribute to insulin resistance (Hoeks and Schrauwen,
2012; Szendroedi et al., 2012). Boosting mitochondrial activity in
rodents improves exercise capacity (Arany et al., 2007; Calvo
et al., 2008; Narkar et al., 2008) and organismal health inCnumerous models of disease ranging from muscle dystrophy to
amyotrophic lateral sclerosis (Da Cruz et al., 2012; Handschin
et al., 2007c).
PGC-1a and PGC-1b have emerged as potent transcriptional
coactivators that regulate broad programs of mitochondrial
biology (Finck and Kelly, 2006; Rowe et al., 2010; Scarpulla,
2008). The PGC-1s also coordinately regulate various ancillary
programs relevant to mitochondria. In muscle, the PGC-1s
coregulate fatty acid transport and angiogenesis—two pro-
cesses that are critical for bringing fuel and oxygen to mito-
chondria (Arany et al., 2008; Madrazo and Kelly, 2008; Rowe
et al., 2011; Vega et al., 2000). The PGC-1s have also been
implicated in regulating genes of the neuromuscular junction
(Handschin et al., 2007c) and muscle-fiber typing (Arany et al.,
2007; Lin et al., 2002), both of which are relevant tomitochondrial
biology in skeletal muscle.
There has been controversy, however, regarding the extent to
which PGC-1a and PGC-1b normally contribute to these mito-
chondrial and ancillary programs. Although gain-of-function
models have been compelling, as outlined above, loss-of-
function experiments have been less conclusive. The extensive
redundancy that exists between PGC-1a and PGC-1b com-
plicates interpretations (Lai et al., 2008; St-Pierre et al., 2003).
Deletion of either PGC-1a or PGC-1b alone, in the whole body
or in skeletal muscle specifically, only mildly affects musclemito-
chondria and function (Handschin et al., 2007a, 2007b; Lai et al.,
2008; Leone et al., 2005; Lin et al., 2004; Sonoda et al., 2007;
Zechner et al., 2010), whereas whole-body deletion of both
coactivators leads to perinatal lethality due to heart failure (Lai
et al., 2008). Evaluation of the role of the PGC-1s in skeletal mus-
cle thus requires deletion of both coactivators specifically in this
tissue. Zechner et al. (2010) recently generated mice in which
PGC-1b is deleted in skeletal muscle and a hypomorphic allele
of PGC-1a is present in all tissues. The authors demonstrated
a dramatic loss of electron transport chain (ETC) activity inell Reports 3, 1449–1456, May 30, 2013 ª2013 The Authors 1449
muscle from these mice, but unchanged fiber types and glucose
handling. However, whole-body PGC-1a deficiency has pro-
found effects on ambulatory activity, metabolism, and diurnal
behavior (Leone et al., 2005; Lin et al., 2004; Liu et al., 2007),
all of which are significant confounders in skeletal muscle
studies. Moreover, the PGC-1a allele used in the experiments
by Zechner et al. (2010) retains intact exons 1–5 (Leone et al.,
2005), which encode the transactivation and nuclear-receptor-
binding domains of PGC-1a, and encode for almost all of
NT-PGC-1a and PGC-1a4, a naturally occurring splice variant
of PGC-1a that is known to retain significant activity (Chang
et al., 2010, 2012; Ruas et al., 2012; Zhang et al., 2009). There-
fore, the mice likely retained some PGC-1 activity in skeletal
muscle. These findings have thus led to controversy (Handschin
and Spiegelman, 2011; Zechner et al., 2011).
In light of these controversies, we used floxed alleles of both
PGC-1a and PGC-1b (Lai et al., 2008; Lin et al., 2004) to generate
animals that lack both coactivators specifically in skeletal
muscle and retain intact expression of both coactivators in other
tissues. We find that ETC activity is severely blunted in these
animals. Surprisingly, however, other aspects of mitochondrial
biology, including mitochondrial density itself, are intact in both
animals and isolated cells. In fact, surprisingly, baseline muscle
function is normal, both in vivo and ex vivo. Similarly, fiber types
are unchanged. Only forced exercise capacity is impaired. Thus,
the data resolve prior controversies and indicate that mitochon-
drial content and ETC capacity are dissociable, that most of ETC
capacity in muscle is dispensable for normal function, and that
PGC-1 coactivators likely serve to ‘‘boost’’ the system and
enable it to withstand stress beyond ordinary activities.
RESULTS
PGC-1a and PGC-1b Are Critical for ETC Capacity
Mice lacking PGC-1a and PGC-1b strictly in skeletal muscle
(double-knockout [DKO] mice) were generated by Cre/Lox
recombination. The PGC-1a and PGC-1b floxed alleles were
kindly provided by Dr. Bruce Spiegelman (Lin et al., 2004) and
Dr. Daniel Kelly (Lai et al., 2008), respectively. Both alleles are
complete nulls after Cre/Lox recombination. Cre recombinase
was driven by a modified myogenin promoter containing the
MEF2 enhancer (Li et al., 2005), an allele widely used for
muscle-specific recombination. The DKO mice were born in
Mendelian ratios and appeared grossly indistinguishable from
their littermate controls. The messenger RNA (mRNA) ex-
pression of both PGC-1a and PGC-1b was reduced by 60% in
quadriceps from DKO animals (Figure 1A). The residual expres-
sion of the PGC-1s likely reflects expression in nonmyocytes, in
which the Cre recombinase is not expressed. PGC-1-related
coactivator (PRC) is a coactivator with weak homology to the
PGC-1s (Rowe et al., 2010; Scarpulla, 2008). The expression of
PRC was not altered in the DKO animals (Figure 1A). Hemato-
xylin and eosin staining of transverse sections from the muscles
showed no obvious abnormalities (Figure S1A).
The mRNA expressions of nuclear genes encoding compo-
nents of the ETC and mitochondrial ATPase were severely
repressed by 60% in quadriceps from DKO animals (Figure 1B).
The RNA expression of genes encoded on the mitochondrial1450 Cell Reports 3, 1449–1456, May 30, 2013 ª2013 The Authorsgenome was similarly repressed (Figure 1C). Soleus and
extensor digitorum longus (EDL) muscles revealed similar find-
ings (Figures S1B and S1C). Western blotting revealed dramatic
decreases in proteins of the ETC and oxidative phosphorylation
(Figures 1D and 1E). The activities of all four complexes of the
ETC and the ATPase complex, measured directly in intact quad-
riceps muscle via state-of-the-art enzymatic spectrophoto-
metric assays (Be´nit et al., 2006; Rowe et al., 2012; Rustin
et al., 1994), were severely depressed, by asmuch as >60% (Fig-
ures 1F and S1D). These marked respiratory defects suggested
that the mice would have blunted exercise capacity. Indeed,
DKO mice were severely limited in their ability to carry out a
treadmill-based exercise stress test (Figures 1G–1J). Together,
these data indicate that DKO mice have profoundly decreased
ETC capacity, which is reflected in marked defects in forced
exercise capacity.
ETC Capacity Is Dispensable for Baseline Activity and
Muscle Function
Surprisingly, spontaneous in-cage locomotor activity was intact
in DKOmice (Figure 2A). However, mice are normally muchmore
active than a standard cage allows them to be. To provide more
opportunity for physical activity, we placed voluntary running
wheels in the cages and monitored them electronically. Both
DKO and control animals voluntarily ran nightly, running
10 hr/day for an approximately calculated total distance of
60–80 km over an 11-day period (Figures 2B and 2C). DKO
mice spent the same amount of time on the wheels (Figure 2D)
as the control animals, and revealed only a mild, statistically
nonsignificant decrease in total running distance (Figure 2E) or
average revolutions/minute (Figure 2F). The mice appeared
healthy at all times (not shown).
To test muscle function in the absence of systemic organismal
effects, we explanted the EDL muscles and tested them ex vivo.
The DKO and control muscles achieved a nearly indistinguish-
able maximum tetanic force of 200 mM/mm2 (Figure 2G),
isometric twitch force of 15 mN/mm2 (Figure 2H), and rate of
fatigability (Figure 2I). Maximum titanic force and fatigability
were similarly preserved in soleus muscles from DKO animals
(Figure S2A–S2C). Muscle contractile function and fatigability
are dependent, to some extent, on the relative makeup of fiber
types. However, the fiber-type compositions of DKO and control
animals were nearly identical in both plantaris and soleus
muscles (Figures 2J, 2K, and S2D). Thus, together, these data
indicate that, surprisingly, DKO mice retain nearly intact fiber-
type composition, baseline muscle activity, and fatigability
both in vivo and ex vivo.
Mitochondrial Content and ETC Capacity Are Separable
In light of the remarkable loss of respiratory chain capacity in
DKO mice (Figure 1), we performed electron microscopy (EM)
to evaluate mitochondria in muscle from DKO animals. Surpris-
ingly, the DKO mitochondria appeared entirely normal in num-
ber, morphology, and overall content (Figures 3A and 3B). The
content of mtDNA was also unperturbed in DKO muscles
(Figure 3C). Regular intermyofibrillar and subsarcolemmal mito-
chondria were seen. No differences in mitochondrial size or
cristae density and morphology were appreciated. Blinded
Figure 1. PGC-1a and PGC-1b Are Critical for ETC Capacity
(A–C) Relative mRNA expression of the indicated genes from quadriceps (quads) of Myo-DKO mice (blue bars) and littermate controls (white bars): PGC-1
isoforms (A), nuclear-encoded ETC genes (B), and mitochondrial-encoded ETC genes (C).
(D and E) Western blot analyses of indicated ETC proteins from quads of Myo-DKO mice.
(F) Relative activity of the indicated ETC complexes in quad muscles from DKO and control animals.
(G) Schematic of the exercise exhaustion protocol.
(H–J) Maximal time (H), work (I), and distance (J) achieved on running treadmills prior to exhaustion. Error bars indicate SEM; n > 3 per group in all panels;
*, p < 0.05. N.S., not statistically significant.
See also Figure S1.experts in mitochondrial morphology were unable to distinguish
between the two genotypes.
These surprising findings indicated that mitochondrial biogen-
esis is separable from assembly of the respiratory chain. Consis-
tent with this notion and the preserved mtDNA content in DKO
muscles, the expression of genes involved in replication of
mtDNAwas not reduced in DKO animals (Figure 3D). Expression
of most genes involved in synthesis of cardiolipin, the pre-
dominant structural mitochondrial lipid, was similarly unaffected,
as were, for the most part, genes involved in other mitochondrial
functions, such as apoptosis, proteolysis, and fusion/fission
(Figure S3A–S3C).
Cell-Autonomous Separation of Mitochondrial Content
and ETC Activity
The observed DKO phenotypes may have had a developmental
origin or may have been affected by cues outside the muscle. To
investigate the above findings in a cell-autonomous setting,
primary muscle myoblasts were isolated from PGC-1a/b homo-
zygous double-floxed animals, exposed to adenoviruses
expressing Cre recombinase (or LacZ as a control), and thenCdifferentiated into myotubes in cell culture. The efficiency of
PGC-1a and PGC-1b deletion was >95% (Figure S3D). Differen-
tiated myotubes appeared grossly normal (Figure S3E) and
showed normal temporal expression of differentiation markers
(Figure S3F), indicating that, interestingly, PGC-1a and PGC-
1b are dispensable for myoblast-to-myotube differentiation in
cell culture.
The mRNA expression of nuclear and mitochondrial re-
spiratory chain components was markedly decreased in DKO
myotubes (Figure 3E), as was the content of Complex I-V pro-
teins (Figure 3F), recapitulating the findings in vivo. The maximal
oxygen consumption rate (OCR) was reduced by 60% in DKO
myotubes, reflecting the marked decreases in components of
the ETC (Figure 3G). On the other hand, basal OCR was unaf-
fected in DKO myotubes (Figure 3G), again indicating that
PGC-1a and PGC-1b are dispensable for baseline function.
OCR in the presence of palmitate as a primary fuel source was
also markedly blunted in DKO myotubes (Figure S3G). State 3
and state 4o respiration (treated with oligomycin) in perme-
abilized myotubes provided with ADP and pyruvate/malate as
substrates was also markedly reduced (Figure 3H).ell Reports 3, 1449–1456, May 30, 2013 ª2013 The Authors 1451
Figure 2. PGC-1s Are Dispensable for Baseline Activity and Muscle Function
(A) In-cage locomotor activity of Myo-DKO mice and control littermates during a 72 hr period.
(B and C) Samples of voluntary wheel activity during 11 days.
(D–F) Quantification of (B) and (C), represented as the percentage of time spent on wheels (D), total distance run (E), and average revolutions per minute (F).
(G–I) Maximal tetanic (G) and isometric (H) twitch forces and contraction-stimulated fatigability (I) of explanted extensor digitorum longus muscle fromMyo-DKO
and control animals.
(J and K) Fiber-type composition in plantaris of DKO and control animals.
(J) Representative images of immunostaining: MHC Ia (red), MHC IIa (blue), and MHC IIb (green); unstained fibers were counted as MHC IId/x.
(K) Quantification of immunostaining. Error bars indicate SEM; n > 6 per group in all panels. N.S., not statistically significant.
See also Figure S2.Finally, transmission EM (TEM) revealed preserved mitochon-
drial content in DKOmyotubes (Figure 3I), again analogous to the
findings in vivo. Mitochondrial content, as quantified by Mito-
Tracker dye, was identical between DKO and control cells (Fig-
ure 3J), as were the steady-state mtDNA amount (Figure 3K)
and expression of genes required for mtDNA replication (Fig-
ure 3L). Altogether, these data indicate that the separation of
mitochondrial content and ETC activity is cell autonomous and
independent of developmental processes. Moreover, despite
profound effects on respiration capacity, PGC-1a and PGC-1b
are dispensable for baseline respiration and myoblast-to-
myotube differentiation.
Direct Visualization of ETC Activity at Resolution
of Cristae
In general, cristae density has been thought to reflect ETC
capacity (Giraud et al., 2002; Strauss et al., 2008). Surprisingly,
however, we found that cristae density was normal in the DKO
animals (Figure 3A).We therefore sought tomeasure ETC activity
in situ, at a magnification sufficient to resolve individual cristae.
We used a recently redeveloped technique in which an elec-
tron-dense trace is generated in situ by Complex IV-mediated
oxidative polymerization of 3,30-diaminobenzidine (DAB) (Zseng-
eller et al., 2012; Figure 4A). The method thus directly visualizes1452 Cell Reports 3, 1449–1456, May 30, 2013 ª2013 The Authorsactively respiring cristae. Images from control animals revealed
uniform contrast throughout the cristae and surrounding mito-
chondrial membrane (presumably the inner membrane;
Figure 4B), consistent with cristae that are packed with ETC
components. In sharp contrast, mitochondria from DKO animals
revealed numerous cristae with only occasional contrast, in a
stippled pattern (Figure 4B, white arrowheads). Some cristae
lacked contrast altogether. No such abnormalities were
observed in the control animals. Thus, these data indicate that
cristae in DKO animals are capable of forming, but have reduced
cytochrome c oxidase (COX) capacity.
DISCUSSION
As outlined above, the precise role of the PGC-1 coactivators in
skeletal muscle at baseline has been the subject of debate
(Handschin and Spiegelman, 2011; Zechner et al., 2011). Here,
we resolved this issue by using alleles of PGC-1a and PGC-1b
that are most likely complete nulls (Handschin et al., 2007b; Lai
et al., 2008), and by using a skeletal-muscle-specific Cre driver
in the context of homozygous floxed alleles, thereby leaving
other tissues unaffected. We conclude that (1) PGC-1a and
PGC-1b are critically required for normal ETC and oxidative
capacity; (2) the PGC-1s do not play a role in baseline fiber-type
Figure 3. Mitochondrial Content and ETC Capacity Are Separable in DKO Muscle and Cultured Myotubes
(A and B) Representative images (A) andmorphometric quantification of themitochondrial density (B) of transmission electronmicrographs of transverse sections
of the midportion of the quads of Myo-DKO mice and control littermates. Sample mitochondria are labeled with a white asterisk.
(C) Mitochondrial-to-nuclear DNA content ratio in quad muscles from Myo-DKO and control animals.
(D) Relative expression of the indicated genes from the quads of Myo-DKO and control animals.
(E–L) Differentiated myotubes from primary myoblasts isolated from DKO (blue) versus control (white) muscles.
(E) Relative mRNA expression of the indicated genes.
(F) Western blot analysis of the indicated ETC proteins.
(G) Basal and uncoupled respiration rates of DKO and control differentiated myotubes.
(H) State 3 and state 4o respiration rates in permeabilized DKO and control differentiated myotubes.
(I) TEM of DKO and control differentiated myotubes.
(J and K) Quantification of mitochondrial content by MitoTracker (J) and mitochondrial-to-nuclear DNA content ratio (K) in DKO and control cells.
(L) Relative expression of the indicated genes in primary DKO and control myotubes (n > 4 fields from 6 animals per group). Error bars indicate SEM; n > 3 per
group in all panels; *, p < 0.05 compared with control; #, p < 0.05 compared with basal state; N.S., not statistically significant.
See also Figure S3.composition; (3) the PGC-1s are dispensable for baselinemuscle
contractile force and fatigability, thus dissociating these pro-
cesses from oxidative capacity in the muscle; and (4) the PGC-
1s are also dispensable for baseline mitochondrial density per
se, thus dissociating this process from oxidative capacity.
Our data suggest that PGC-1 coactivators are dispensable for
most of the developmental and hormonal cues that determine
muscle differentiation and fiber-type composition (Schiaffino
and Reggiani, 2011). Consistent with this notion, deletion of
the PGC-1s did not affect myoblast-to-myotube differentiation
in cell culture (Figure S3). On the other hand, gain-of-function
models convincingly demonstrated the ability of PGC-1s to drive
fiber-type conversion (Arany et al., 2007; Lin et al., 2002). These
observations suggest that the PGC-1s primarily transduce post-
natal physiological signals to affect fiber-type composition.
Exercise, for example, is known to induce PGC-1a and changes
in fiber types. Muscle PGC-1a alone is dispensable for exercise-
induced fiber-type transformation and mitochondrial biogenesis
(Geng et al., 2010; Rowe et al., 2012), suggesting that redun-
dancy with PGC-1b may be important in this context. If so,Cthen PGC-1b may be modified by exercise at the posttransla-
tional level, since, in contrast to PGC-1a, levels of PGC-1b
transcripts are typically not affected by exercise. Consistent
with this notion, PGC-1b is stabilized by cyclic AMP signaling
(Shoag et al., 2013).
It is striking that mice lacking >60% of muscle oxidative
capacity remain capable of normal locomotion, and indeed of
voluntarily running up to 10 km per night (Figure 2). The dissoci-
ation of these processes demonstrates that oxidative capacity in
skeletal muscle is not primarily rate limiting for most baseline
activities. The data also indicate that the ‘‘comfort zone’’ rate
at which mice voluntarily run on in-cage wheels is determined
by factors other than oxidative capacity. Fatigue, be it experi-
enced or physiological, is a significant burden faced by patients
withmyopathies and has a large impact on their perceived health
status. The low workload fatigue experienced by these patients
is likely mechanistically different from that experienced by
higher-intensity work such as endurance running. The data
presented here suggest that mitochondrial insufficiency in these
patients may not account for their fatigue.ell Reports 3, 1449–1456, May 30, 2013 ª2013 The Authors 1453
Figure 4. Decreased Ultrastructural ETC
Activity in Myo-PGC-1DKO Animals
(A) Schematic of DAB polymerization.
(B) TEM ultrastructural analysis of mitochondrial
COX enzymatic activity in quadriceps muscle of
Myo-DKO animals and control littermates. Punc-
tate mitochondrial cristae are labeled with a white
arrowhead.DKO cells and muscles contained normal amounts of mito-
chondria and cristae, despite profound decreases in ETC
capacity. The regulation of these two processes is thus sepa-
rable. mtDNA content was also normal in DKO animals and
cells, as was the expression of genes involved in mitochondrial
genome replication (Figure 3D). Thus, the PGC-1s are not rate
limiting for mtDNA content in skeletal muscle. Coordinated
regulation of genes involved in cardiolipin biosynthesis was
also unaltered in DKO animals and cells. It thus appears that
a different threshold of required PGC-1 activity exists for genes
of the ETC compared with other mitochondrial functions. It will
be of interest in the future to determine whether this involves
binding to different transcription factors and/or altered post-
translational modifications. PRC, a coactivator with weak
homology to the PGC-1s, may play a role, although we did
not observe compensatory upregulation of PRC in the DKO
animals.
High-resolution visualization of cytochrome oxidase activity
intriguingly revealed a stippled pattern of activity along cristae
in DKO animals, in contrast to the continuous activity seen in
control animals. Assembly of ETC complexes is known to be
tightly regulated and exquisitely stoichiometric (Lenaz and
Genova, 2010; Papa et al., 2012). The discontinuous pattern of
staining on EM thus suggests that ETC complexes form normally
at some sites on the cristae, but not at all at other sites. This
pattern may be favored because less dense packing of ETC
components along the cristae may not allow proper substrate
shuttling (Giraud et al., 2002; Strauss et al., 2008).
In summary, the present study resolves important contro-
versies concerning the role of PGC-1a and PGC-1b in skeletal
muscle, and in the process also demonstrates that oxidative
capacity in muscle is surprisingly dissociable frommitochondrial
content, from isolated muscle contractility, and from normal
organismal activity and fatigability.1454 Cell Reports 3, 1449–1456, May 30, 2013 ª2013 The AuthorsEXPERIMENTAL PROCEDURES
All animal experiments were performed according
to procedures approved by the Beth Israel
Deaconess Medical Center IACUC. PGC-1a
floxed mice (Lin et al., 2004), PGC-1b floxed
mice (Lai et al., 2008), and Myogenin/MEF2-Cre
driver (Li et al., 2005) have been described previ-
ously. Respiratory chain complex activity was
measured as previously described (Be´nit et al.,
2006; Rustin et al., 1994). EM was performed by
the BIDMC Electron Micrograph Core. Functional
COX EM was performed as previously described
(Zsengeller et al., 2012). OCRs (pmol/min) were
assessed with the use of an XF Flux Analyzer
(Seahorse Biosciences). Data are presented asmeans ± SEM. Statistical analysis was performed with Student’s t test for all
in vitro experiments, and ANOVAs were performed for all in vivo experiments;
p values of <0.05 were considered statistically significant.
For more details regarding the materials and methods used in this work, see
the Extended Experimental Procedures.
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